Drugs & Targets FDA approves Ogivri, first biosimilar for treating breast and stomach cancers December 01, 2017Vol.43 No.44
Drugs & Targets Tesaro receives European approval of Zejula for recurrent ovarian cancer December 01, 2017Vol.43 No.44
Drugs & Targets G1 Therapeutics and AstraZeneca enter clinical trials collaboration in NSCLC December 01, 2017Vol.43 No.44
Drugs & Targets ITUS Corp. Moffitt enter into CRADA to develop CAR-T technology December 01, 2017Vol.43 No.44
In Brief National Academies report calls for government negotiation of drug prices December 01, 2017Vol.43 No.44
In Brief Antonio Wolff named chair of ECOG-ACRIN Breast Cancer Committee December 01, 2017Vol.43 No.44
In Brief LLS awards $5 million grant to team led by Sylvester’s Stephen Nimer December 01, 2017Vol.43 No.44
In Brief Ronda Henry-Tillman named to Kohn Chair in breast surgical oncology UAMS December 01, 2017Vol.43 No.44
